Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments

A M H Krebber, L M Buffart, G Kleijn, I C Riepma, R de Bree, C R Leemans, A Becker, J Brug, A van Straten, P Cuijpers, I M Verdonck-de Leeuw, A M H Krebber, L M Buffart, G Kleijn, I C Riepma, R de Bree, C R Leemans, A Becker, J Brug, A van Straten, P Cuijpers, I M Verdonck-de Leeuw

Abstract

Objective: We aimed to investigate the prevalence of depression in cancer patients assessed by diagnostic interviews and self-report instruments, and to study differences in prevalence between type of instrument, type of cancer and treatment phase.

Methods: A literature search was conducted in four databases to select studies on the prevalence of depression among adult cancer patients during or after treatment. A total of 211 studies met the inclusion criteria. Pooled mean prevalence of depression was calculated using Comprehensive Meta-Analysis.

Results: Hospital Anxiety and Depression Scale-depression subscale (HADS-D) ≥ 8, HADS-D ≥11, Center for Epidemiologic Studies ≥ 16, and (semi-)structured diagnostic interviews were used to define depression in 66, 53, 35 and 49 studies, respectively. Respective mean prevalence of depression was 17% (95% CI = 16-19%), 8% (95% CI = 7-9%), 24% (95% CI = 21-26%), and 13% (95% CI = 11-15%) (p < 0.001). Prevalence of depression ranged from 3% in patients with lung cancer to 31% in patients with cancer of the digestive tract, on the basis of diagnostic interviews. Prevalence of depression was highest during treatment 14% (95% CI = 11-17%), measured by diagnostic interviews, and 27% (95% CI = 25-30%), measured by self-report instruments. In the first year after diagnosis, prevalence of depression measured with diagnostic interviews and self-report instruments were 9% (95% CI = 7-11%) and 21% (95% CI = 19-24%), respectively, and they were 8% (95% CI = 5-12%) and 15% (95% CI = 13-17%) ≥ 1 year after diagnosis.

Conclusions: Pooled mean prevalence of depression in cancer patients ranged from 8% to 24% and differed by the type of instrument, type of cancer and treatment phase. Future prospective studies should disentangle whether differences in prevalence of depression are caused by differences in the type of instrument, type of cancer or treatment phase. © 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.

Keywords: cancer; depression; epidemiology; meta-analysis; neoplasms; oncology.

© 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.

Figures

Figure 1
Figure 1
Selection of studies
Figure 2
Figure 2
Bias risk assessment of 159 studies: number of studies per rating (a) and percentage of studies with a positive score at item level (b)

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. IARC CancerBase No. 10 [Internet] Lyon, France: International Agency for Research on Cancer; 2010. GLOBOCAN 2008 v 1.2, cancer incidence and mortality worldwide. Available from: , accessed on 23/01/2012.
    1. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–757.
    1. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330:702.
    1. Prieto JM, Blanch J, Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20:1907–1917.
    1. Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000;356:1326–1327.
    1. Yousaf U, Christensen ML, Engholm G, Storm HH. Suicides among Danish cancer patients 1971–1999. Br J Cancer. 2005;92:995–1000.
    1. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
    1. Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464–1488.
    1. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–174.
    1. American Psychiatric Association. In Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Press; 1994.
    1. WHO. In The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.
    1. Newport DJ, Nemeroff CB. Assessment and treatment of depression in the cancer patient. J Psychosom Res. 1998;45:215–237.
    1. Mitchell AJ, Lord K, Symonds P. Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord. 2012;138:137–148.
    1. Sollner W, DeVries A, Steixner E, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84:179–185.
    1. Vachon ML. Caring for the caregiver in oncology and palliative care. Semin Oncol Nurs. 1998;14:152–157.
    1. Sharp LK, Lipsky MS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician. 2002;66:1001–1008.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.
    1. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
    1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
    1. Derogatis LR. In Brief Symptom Inventory: Administration, Scoring and Procedures Manual. 3. Minneapolis, MN: National Computer Systems; 1993.
    1. Luppa M, Sikorski C, Luck T, et al. Age- and gender-specific prevalence of depression in latest-life—systematic review and meta-analysis. J Affect Disord. 2010 S0165-0327(10)00730-5 [pii]; doi: .
    1. Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005;41:2613–2619.
    1. Chinapaw MJ, Proper KI, Brug J, van Mechelen W, Singh AS. Relationship between young peoples' sedentary behaviour and biomedical health indicators: a systematic review of prospective studies. Obes Rev. 2011;12:e621–e632.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
    1. Akechi T, Okamura H, Yamawaki S, Uchitomi Y. Why do some cancer patients with depression desire an early death and others do not? Psychosomatics. 2001;42:141–145.
    1. Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer. 2001;92:2609–2622.
    1. Dausch BM, Compas BE, Beckjord E, et al. Rates and correlates of DSM-IV diagnoses in women newly diagnosed with breast cancer. J Clin Psychol Med Settings. 2004;11:159–169.
    1. Fritzsche K, Struss Y, Hammel A, Bertz H, Stein B. Relationship between psychosocial distress, treatment need and use of psychotherapeutic interventions within a psychosomatic liaison service in hematological oncology. Onkologie. 2004;27:457–461.
    1. Gil F, Costa G, Perez FJ. Does chemotherapy reduce stress? Palliat Support Care. 2010;8:455–460.
    1. Gilbert J, Haman KL, Dietrich MS, Blakely RD, Shelton RC, Murphy BA. Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene. Head Neck. 2012;34:359–364.
    1. Grassi L, Malacarne P, Maestri A, Ramelli E. Depression, psychosocial variables and occurrence of life events among patients with cancer. J Affective Disord. 1997;44:21–30.
    1. Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004;38:320–326.
    1. McCaffrey JC, Weitzner M, Kamboukas D, Haselhuhn G, LaMonde L, Booth-Jones M. Alcoholism, depression, and abnormal cognition in head and neck cancer: a pilot study. Otolaryngology - Head & Neck Surgery. 2007;136:92–97.
    1. Palmer SC, Kagee A, Coyne JC, DeMichele A. Experience of trauma, distress, and posttraumatic stress disorder among breast cancer patients. Psychosom Med. 2004;66:258–264.
    1. Pirl WF, Greer J, Temel JS, Yeap BY, Gilman SE. Major depressive disorder in long-term cancer survivors: analysis of the National Comorbidity Survey Replication. J Clin Oncol. 2009;27:4130–4134.
    1. Popoola AO, Adewuya AO. Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psycho-Oncology. 2012;21:675–679. doi: .
    1. Schrier M, Amital D, Arnson Y, et al. Association of fibromyalgia characteristics in patients with non-metastatic breast cancer and the protective role of resilience. Rheumatol Int. 2011
    1. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49:124–138.
    1. Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004:80–92.
    1. Akechi T, Ietsugu T, Sukigara M, et al. Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. Gen Hosp Psychiatry. 2009;31:225–232.
    1. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998;16:1594–1600.
    1. Weissman MM, Neria Y, Gameroff MJ, et al. Positive screens for psychiatric disorders in primary care: a long-term follow-up of patients who were not in treatment. Psychiatr Serv. 2010;61:151–159.
    1. Mitchell AJ, Meader N, Davies E, et al. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression In Cancer Care consensus group. J Affect Disord. 2012;140:149–160.
    1. Fann JR, Thomas-Rich AM, Katon WJ, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30:112–126.
    1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–627.
    1. Seedat S, Scott KM, Angermeyer MC, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66:785–795.
    1. Lee MS, Love SB, Mitchell JB, et al. Mastectomy or conservation for early breast cancer: psychological morbidity. Eur J Cancer. 1992;28A:1340–1344.
    1. Lam WW, Bonanno GA, Mancini AD, et al. Trajectories of psychological distress among Chinese women diagnosed with breast cancer. Psycho-Oncology. 2010;19:1044–1051.
    1. Verdonck-de Leeuw IM, de Bree R, Keizer AL, et al. Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol. 2009;45:e129–e133.
    1. Dunn J, Ng SK, Holland J, et al. Trajectories of psychological distress after colorectal cancer. Psycho-Oncology. 2012;22:1759–1765.
    1. Fava GA, Park SK, Sonino N. Treatment of recurrent depression. Expert Rev Neurother. 2006;6:1735–1740.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться